LMRI's Quality Score fell 1 point on Tue, Nov 10, to 4. Buying slipped from its highest in 20 days (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 25% from Nov 2 to Nov 10.
| Holding it back | 38.1% more shares than a year ago |
| Latest filing | 8-K, Nov 10 |
ReportToday after the close: the results are out. Raised its outlook for the year. Past reports ›
Fri Dec 11: One year since its IPOListed Dec 11, 2025 at $18.50.
Expected to report Thu Mar 25, after the close
Below Averagefor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means
LMRI is #15 of 18 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 15 |
Expected to report Thu Mar 25, after the close (in 135 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“Raising guidance for Adjusted EPS to $0.86 to $0.90 from $0.71 to $0.77 per share, driven by lower assumed effective tax rate.”
LMRI's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Adjusted EPS | $0.86 to $0.90 |
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Aug 12, 2026 | +0.5% | +4.0% | +1.0% |
| May 12, 2026 | +0.6% | -23.3% | -33.3% |
| Mar 26, 2026 | -24.1% | -29.8% | -15.0% |
RSI 78.4, MACD above signal, above both averages. Not scored.
One insider bought $254K across 1 filing in the last 6 months. No open-market sales on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: LMRI is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
Listed on Nasdaq on Dec 11, 2025, and is 25% below its $18.50 offer price now. Its IPO filing and first days
LMRI scores 4 today, which Breakaway calls Below Average. It is #15 of 18 in Services-Medical Laboratories by Quality Score, with 4 of 14 chart checks firing. Up 25% from Nov 2 to Nov 10. Shares: 38.1% more than a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
LMRI scores 4 today, which Breakaway calls Below Average (0 to 5). That is #15 of 18 in Services-Medical Laboratories by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind LMRI's 4.
One insider bought $254K across 1 filing in the last 6 months. No open-market sales on record. The newest is Brett Brodnax, Director, who bought $254K on May 19.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.